Friday, July 17, 2009

Gastric banding or bypass? (Neither is Very Good).

Weight loss outcomes strongly favored Roux-en-Y gastric bypass over laparoscopic adjustable gastric banding. Patients treated with laparoscopic adjustable gastric banding had lower short-term morbidity than those treated with Roux-en-Y gastric bypass, but reoperation rates were higher among patients who received laparoscopic adjustable gastric banding.

Am J Med. 2008 Oct;121(10):885-93.
Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures.
Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD.

Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-1732, USA. jtice@medicine.ucsf.edu
Roux-en-Y gastric bypass is superior to gastric banding, There is mounting and convincing evidence that laparoscopic gastric banding is suboptimal

University of Toronto, Department of Surgery, Toronto, ON, M3N 1N1, Canada. uguller@yahoo.com.

ABSTRACT: BACKGROUND: The use of bariatric surgery in the management of morbid obesity is rapidly increasing. The two most frequently performed procedures are laparoscopic Roux-en-Y bypass and laparoscopic gastric banding. The objective of this short overview is to provide a critical appraisal of the most relevant scientific evidence comparing laparoscopic gastric banding versus laparoscopic Roux-en-Y bypass in the treatment of morbidly obese patients. RESULTS AND DISCUSSION: There is mounting and convincing evidence that laparoscopic gastric banding is suboptimal at best in the management of morbid obesity. Although short-term morbidity is low and hospital length of stay is short, the rates of long-term complications and band removals are high, and failure to lose weight after laparoscopic gastric banding is prevalent. CONCLUSION: The placement of a gastric band appears to be a disservice to many morbidly obese patients and therefore, in the current culture of evidence based medicine, the prevalent use of laparoscopic gastric banding can no longer be justified. Based on the current scientific literature, the laparoscopic gastric bypass should be considered the treatment of choice in the management of morbidly obese patients.
Patient Saf Surg. 2009 May 29;3(1):10.
Debra H. to Mini-Gastric-B.
Jul 16

Hello to all…..
Just checking in on my 6 year anniversary! Can’t believe it has already been 6 years! The journey has been great! No complications, maintaining my weight… well up and down 5-8 pounds at times. The MGB and Dr. R truly changed my life! Life is good!
Those considering gastric by pass, do your research and make a decision that is best for you, I know for me the MGB was far above all others. My step daughter had an RNY and has had complications. Just last month at 2 years out from her RNY she had emergency surgery due to complications.
MGB is truly life changing. The health improvements have been the most important changes. Sometimes I forget I was obese, but then I see the discrimination and ridicule obese people face and it makes me remember the emotional pain I felt when I was obese. It makes me angry. I truly believe obesity is the last discrimination tolerated in our society.
I am proof the MGB when used as a tool works long term weight loss and maintenance.
I can honestly say…. 6 years into my MGB journey life is great!
God Bless,
Debra H. in San Antonio, TX
Dr. R. 7-16-03
240 high 212 day of surgery… NOW… 132 size 6 & 4

Monday, June 29, 2009

http://ping.fm/XoaOW

Address the public health problem of liver injury related to the use of acetaminophen (Tylenol)

Acetaminophen is one of the most commonly used drugs in the United States,1 yet it is also an important cause of serious liver injury. Acetaminophen is the generic name of a drug found in many common brand name over-the-counter (OTC) products, such as Tylenol
http://ping.fm/7fdRZ

FDA Requires Additional Labeling For Over-the-Counter Pain Relievers And Fever Reducers To Help Consumers Use Products Safely
Over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks, such as internal bleeding and liver damage
http://ping.fm/TIbFE

FDA Recommends Tougher Standards for Acetaminophen: when taken over the maximum amount of 4 grams per day, acetaminophen can cause liver damage, ranging from abnormalities in blood tests used to assess liver function to acute liver failure (ALF), and even death

Tuesday, April 28, 2009

American Society for Metabolic and Bariatric Surgery centers of excellence Don't Deliver!
http://ping.fm/Oc5Rb
doesn't
reduce a patient's risk of complications or death!!!